Dr. Edward D. Walshe, MD

Dr. Walshe practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Walshe's NPI, 1073688099, was assigned on November 22, 2006. Dr. Walshe holds Massachusetts license 204386.

Dr. Walshe's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Walshe's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Dr. Walshe is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Walshe to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Walshe practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Walshe's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Walshe is board certified in nephrology by the American Board of Internal Medicine. Dr. Walshe is licensed in Massachusetts.

CMS data shows 1,450 Medicare services from Dr. Walshe across 7 procedure codes in 2024, for 311 Medicare patients. Medicare paid $121,167 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 311 Medicare patients who saw Dr. Walshe in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 4.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Walshe's median patient age at 67, with 32% women.

In 2024, Dr. Walshe wrote 1,917 Medicare Part D claims for 224 patients. 97% of them were for generic drugs. CMS names the drug for 1,656 of them, across 40 drugs with 11 or more claims each, at $65,788 in total drug cost. In 2023, CMS named 1,443 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Walshe for performance year 2024, reported through an alternative payment model (APM). Dr. Walshe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Walshe as offering telehealth.

Dmand AI links 1 paper to Dr. Walshe in 2020. Dr. Walshe's most frequent co-authors are Kenneth A. Bodziak, MD, Francesca Cardarelli, MD and Michael Charles Chobanian, MD.

Dmand AI links Dr. Walshe to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 15 general payments to Dr. Walshe from 4 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $401.